Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Macy’s, Inc. (M),, Inc. (AMZN): Why J.C. Penney Company, Inc. (JCP)’s “Poison Pill” Isn’t Good for Investors

Bricks and mortar are nice, but are still losing relevance, Inc. (NASDAQ:AMZN) is continuing to show how true this is. J.C. Penney Company, Inc. (NYSE:JCP), Macy’s, Inc. (NYSE:M), Target, and Wal-Mart all showed flat-to-poor results in the latest quarter, while sales at, Inc. (NASDAQ:AMZN) were up 22%.  And while there were rumors about a year ago that the company was planning to test retail stores, this hasn’t happened. What has happened, though, is the company is expanding Amazon Locker, and testing same-day shipping in limited markets.

Simply put, the strong growth of its traditional web business is funding the company’s attempts to come full-circle to the last vestige of benefits for many bricks and mortar stores: buy it today, get it today. Don’t get me wrong; consumers aren’t going to just stop going to stores tomorrow. But the pull of convenience is very powerful, as, Inc. (NASDAQ:AMZN)’s continual growth testifies.

So what’s this have to do with Penney?

Management has yet to demonstrate that:

It has a plan

Can execute that plan, and stick to it

Said plan will yield positive results, Inc. (NASDAQ:AMZN) and Macy’s, on the other hand, are executing on all three.

Final thoughts

Until J.C. Penney Company, Inc. (NYSE:JCP) shows us that it can execute a plan to regain lost customers, expand its Internet business, and return to profitability, investors are better off looking elsewhere., Inc. (NASDAQ:AMZN)’s valuation may be sky-high, but so is its growth rate, while traditional retail competitors are losing traction. Because of its high valuation and share price volatility, investors are best served by starting small and building a position over time. Chances are, mister market will help you get better prices if you’re patient. Just don’t expect, Inc. (NASDAQ:AMZN) to ever be a bargain stock.

Macy’s, Inc. (NYSE:M) may not be anything like the growth story that Amazon is, but management is doing a worthy job of managing expenses, as well as returning capital to shareholders through dividends and share buybacks. The number one thing it offer investments today, versus J.C. Penney Company, Inc. (NYSE:JCP)? A track record of success, and a predictable path to more profits. And that’s worth a lot more than a “Penney.”

The article Why J.C. Penney’s “Poison Pill” Isn’t Good for Investors originally appeared on and is written by Jason Hall.

Jason Hall owns shares of The Motley Fool recommends The Motley Fool owns shares of

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.